Pharmacological Inhibition of Interleukin-8 (CXCL8) as a New Approach for the Prevention and Treatment of Several Human Diseases

ISSN: 1875-614X (Online)
ISSN: 1871-5230 (Print)


Volume 15, 3 Issues, 2016


Download PDF Flyer




Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry

Formerly: Current Medicinal Chemistry - Anti-Inflammatory and Anti-Allergy Agents

This journal supports open access

Aims & ScopeAbstracted/Indexed in


Submit Abstracts Online Submit Manuscripts Online

Editor-in-Chief:
Claudiu T. Supuran
Neurofarba Department
University of Florence
Florence
Italy


View Full Editorial Board

Subscribe Purchase Articles Order Reprints


Pharmacological Inhibition of Interleukin-8 (CXCL8) as a New Approach for the Prevention and Treatment of Several Human Diseases



Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry, 2(1): 67-79.

Author(s): Cinzia Bizzarri, Marcello Allegretti, Rosa Di Bitondo, Maria Neve Cervellera, Francesco Colotta and Riccardo Bertini.

Affiliation: Dompe Research and Development, Dompe s.p.a., L'Aquila, Italy

Abstract

Interleukin-8 (CXCL8) belongs to the CXC branch of chemokine family and is primarily involved in the directed migration and functional activation of polymorphonuclear neutrophil leukocytes (PMNs). CXCL8 achieves its cellular effects by direct interaction with cell surface receptors (CXCR1 and CXCR2). CXCL8 is supposed to play a pivotal role in the pathology of several inflammatory diseases and this makes CXCL8 and its receptors attractive therapeutic targets. The first aim of this review is to discuss the potential pathophysiological role of CXCL8 in different pathologies, such as ischaemia / reperfusion injury, psoriasis, cystic fibrosis, and cutaneous melanoma. CXCL8 inhibitors, including a monoclonal neutralizing antibody of CXCL8, and small organic molecules which selectively inhibit CXCL8 receptor binding, will be reviewed. Finally, the ability of some non-steroidal anti-inflammatory drugs (NSAIDs) to inhibit CXCL8-induced PMN chemotaxis will also be discussed.

Keywords:

CXCL8, melanoma, non-steroidal anti-inflammatory drugs (NSAIDs), PMN chemotaxis.



Download Free Order Reprints Order Eprints Rights and Permissions




Article Details

Volume: 2
Issue Number: 1
First Page: 67
Last Page: 79
Page Count: 13
DOI: 10.2174/1568014033355844
Advertisement

Related Journals




Webmaster Contact: urooj@benthamscience.org Copyright © 2016 Bentham Science